Every peng stock price prediction I have seen this month sits inside a spread so wide it is basically a coin flip.
Barclays cut to underweight on 20 July with a $40 target. Citizens is at $85 outperform, Needham and Rosenblatt at $80, Stifel at $75. Published consensus figures land somewhere between $63 and $74. One fair value estimate sits near $38.
The quarter itself was strong. Revenue about $479M, up roughly 48% year on year, EPS $0.84 versus $0.55 expected, full-year guidance raised to around 22% sales growth, preliminary FY2027 near 30%.
The argument is about the multiple, not the numbers. PE near 38, beta near 2.83, 52-week range roughly $16 to $90.
I trade the PENGSTOCKUSDT perpetual on Bitunix around levels rather than forecasts, in small size. It is a derivative with funding costs and liquidation risk, not ownership. Next catalyst is the October report. My timing can be wrong, so do your own work.
Barclays cut to underweight on 20 July with a $40 target. Citizens is at $85 outperform, Needham and Rosenblatt at $80, Stifel at $75. Published consensus figures land somewhere between $63 and $74. One fair value estimate sits near $38.
The quarter itself was strong. Revenue about $479M, up roughly 48% year on year, EPS $0.84 versus $0.55 expected, full-year guidance raised to around 22% sales growth, preliminary FY2027 near 30%.
The argument is about the multiple, not the numbers. PE near 38, beta near 2.83, 52-week range roughly $16 to $90.
I trade the PENGSTOCKUSDT perpetual on Bitunix around levels rather than forecasts, in small size. It is a derivative with funding costs and liquidation risk, not ownership. Next catalyst is the October report. My timing can be wrong, so do your own work.